Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 195

1.

Detection of non-aggressive stage IA lung cancer using chest computed tomography and positron emission tomography/computed tomography.

Shiono S, Yanagawa N, Abiko M, Sato T.

Interact Cardiovasc Thorac Surg. 2014 Oct;19(4):637-43. doi: 10.1093/icvts/ivu188. Epub 2014 Jul 3.

2.

Tumour standardized uptake value on positron emission tomography is a novel predictor of adenocarcinoma in situ for c-Stage IA lung cancer patients with a part-solid nodule on thin-section computed tomography scan.

Hattori A, Suzuki K, Matsunaga T, Fukui M, Tsushima Y, Takamochi K, Oh S.

Interact Cardiovasc Thorac Surg. 2014 Mar;18(3):329-34. doi: 10.1093/icvts/ivt500. Epub 2013 Dec 18.

3.

Oncologic outcomes of segmentectomy compared with lobectomy for clinical stage IA lung adenocarcinoma: propensity score-matched analysis in a multicenter study.

Tsutani Y, Miyata Y, Nakayama H, Okumura S, Adachi S, Yoshimura M, Okada M.

J Thorac Cardiovasc Surg. 2013 Aug;146(2):358-64. doi: 10.1016/j.jtcvs.2013.02.008. Epub 2013 Mar 8.

PMID:
23477694
4.

Prediction of pathologic node-negative clinical stage IA lung adenocarcinoma for optimal candidates undergoing sublobar resection.

Tsutani Y, Miyata Y, Nakayama H, Okumura S, Adachi S, Yoshimura M, Okada M.

J Thorac Cardiovasc Surg. 2012 Dec;144(6):1365-71. doi: 10.1016/j.jtcvs.2012.07.012. Epub 2012 Aug 9.

PMID:
22883546
5.

Limited resection for clinical Stage IA non-small-cell lung cancers based on a standardized-uptake value index.

Shiono S, Abiko M, Sato T.

Eur J Cardiothorac Surg. 2013 Jan;43(1):e7-e12. doi: 10.1093/ejcts/ezs573. Epub 2012 Nov 4.

PMID:
23129358
6.

Segmentectomy for clinical stage IA lung adenocarcinoma showing solid dominance on radiology.

Tsutani Y, Miyata Y, Nakayama H, Okumura S, Adachi S, Yoshimura M, Okada M.

Eur J Cardiothorac Surg. 2014 Oct;46(4):637-42. doi: 10.1093/ejcts/ezt645. Epub 2014 Jan 28.

PMID:
24477740
7.

Sublobar resection for lung adenocarcinoma meeting node-negative criteria on preoperative imaging.

Tsutani Y, Miyata Y, Nakayama H, Okumura S, Adachi S, Yoshimura M, Okada M.

Ann Thorac Surg. 2014 May;97(5):1701-7. doi: 10.1016/j.athoracsur.2014.02.024. Epub 2014 Mar 26.

PMID:
24679941
8.

Positron emission tomography for predicting recurrence in stage I lung adenocarcinoma: standardized uptake value corrected by mean liver standardized uptake value.

Shiono S, Abiko M, Okazaki T, Chiba M, Yabuki H, Sato T.

Eur J Cardiothorac Surg. 2011 Nov;40(5):1165-9. doi: 10.1016/j.ejcts.2011.02.041. Epub 2011 Apr 19.

PMID:
21507671
9.

Prognostic significance of using solid versus whole tumor size on high-resolution computed tomography for predicting pathologic malignant grade of tumors in clinical stage IA lung adenocarcinoma: a multicenter study.

Tsutani Y, Miyata Y, Nakayama H, Okumura S, Adachi S, Yoshimura M, Okada M.

J Thorac Cardiovasc Surg. 2012 Mar;143(3):607-12. doi: 10.1016/j.jtcvs.2011.10.037. Epub 2011 Nov 20.

PMID:
22104678
10.

Prognostic role of positron emission tomography and high-resolution computed tomography in clinical stage IA lung adenocarcinoma.

Uehara H, Tsutani Y, Okumura S, Nakayama H, Adachi S, Yoshimura M, Miyata Y, Okada M.

Ann Thorac Surg. 2013 Dec;96(6):1958-65. doi: 10.1016/j.athoracsur.2013.06.086. Epub 2013 Sep 7.

PMID:
24021765
11.

Simple preoperative computed tomography image analysis shows good predictive performance for pathological vessel invasion in clinical stage IA non-small cell lung cancer.

Ito T, Murakawa T, Sato H, Tanabe A, Maekawa M, Yoshida Y, Fukayama M, Nakajima J.

Interact Cardiovasc Thorac Surg. 2012 Oct;15(4):633-8. Epub 2012 Jun 27.

12.

Tumor invasiveness as defined by the newly proposed IASLC/ATS/ERS classification has prognostic significance for pathologic stage IA lung adenocarcinoma and can be predicted by radiologic parameters.

Takahashi M, Shigematsu Y, Ohta M, Tokumasu H, Matsukura T, Hirai T.

J Thorac Cardiovasc Surg. 2014 Jan;147(1):54-9. doi: 10.1016/j.jtcvs.2013.08.058. Epub 2013 Oct 13.

PMID:
24131786
13.

Role of 2-[18F]fluoro-2-deoxyglucose positron emission tomography in preoperative management of solid-type small-sized lung cancer.

Saisho S, Yasuda K, Maeda A, Yukawa T, Okita R, Hirami Y, Shimizu K, Nakata M.

Ann Nucl Med. 2013 Jul;27(6):515-22. doi: 10.1007/s12149-013-0715-7. Epub 2013 Mar 16.

PMID:
23504519
14.

False-negative rate after positron emission tomography/computer tomography scan for mediastinal staging in cI stage non-small-cell lung cancer.

Gómez-Caro A, Boada M, Cabañas M, Sanchez M, Arguis P, Lomeña F, Ramirez J, Molins L.

Eur J Cardiothorac Surg. 2012 Jul;42(1):93-100; discussion 100. doi: 10.1093/ejcts/ezr272. Epub 2012 Jan 20.

PMID:
22290911
15.

Multicenter analysis of high-resolution computed tomography and positron emission tomography/computed tomography findings to choose therapeutic strategies for clinical stage IA lung adenocarcinoma.

Okada M, Nakayama H, Okumura S, Daisaki H, Adachi S, Yoshimura M, Miyata Y.

J Thorac Cardiovasc Surg. 2011 Jun;141(6):1384-91. doi: 10.1016/j.jtcvs.2011.02.007. Epub 2011 Mar 25.

PMID:
21440264
16.

Predictive value of 18F-FDG PET and CT morphologic features for recurrence in pathological stage IA non-small cell lung cancer.

Ko KH, Hsu HH, Huang TW, Gao HW, Cheng CY, Hsu YC, Chang WC, Chu CM, Chen JH, Lee SC.

Medicine (Baltimore). 2015 Jan;94(3):e434. doi: 10.1097/MD.0000000000000434.

17.

Revisiting the prognostic value of preoperative (18)F-fluoro-2-deoxyglucose ( (18)F-FDG) positron emission tomography (PET) in early-stage (I & II) non-small cell lung cancers (NSCLC).

Agarwal M, Brahmanday G, Bajaj SK, Ravikrishnan KP, Wong CY.

Eur J Nucl Med Mol Imaging. 2010 Apr;37(4):691-8. doi: 10.1007/s00259-009-1291-x. Epub 2009 Nov 14.

18.

Radiologic and nuclear medicine predictors of tumor invasiveness in patients with clinical stage IA lung adenocarcinoma.

Tamura M, Oda M, Matsumoto I, Shimizu Y, Waseda R, Watanabe G.

World J Surg. 2011 Sep;35(9):2010-5. doi: 10.1007/s00268-011-1145-0.

PMID:
21633846
19.

CyberKnife radiosurgery for inoperable stage IA non-small cell lung cancer: 18F-fluorodeoxyglucose positron emission tomography/computed tomography serial tumor response assessment.

Vahdat S, Oermann EK, Collins SP, Yu X, Abedalthagafi M, Debrito P, Suy S, Yousefi S, Gutierrez CJ, Chang T, Banovac F, Anderson ED, Esposito G, Collins BT.

J Hematol Oncol. 2010 Feb 4;3:6. doi: 10.1186/1756-8722-3-6.

20.

Associations among bronchioloalveolar carcinoma components, positron emission tomographic and computed tomographic findings, and malignant behavior in small lung adenocarcinomas.

Okada M, Tauchi S, Iwanaga K, Mimura T, Kitamura Y, Watanabe H, Adachi S, Sakuma T, Ohbayashi C.

J Thorac Cardiovasc Surg. 2007 Jun;133(6):1448-54.

PMID:
17532938
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk